These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 17388966)

  • 1. Inflammatory/hemostatic biomarkers and cardiovascular risk: coming of age?
    Lowe GD
    J Thromb Haemost; 2007 Jun; 5(6):1125-7. PubMed ID: 17388966
    [No Abstract]   [Full Text] [Related]  

  • 2. Inflammation and hemostasis biomarkers and cardiovascular risk in the elderly: the Cardiovascular Health Study.
    Zakai NA; Katz R; Jenny NS; Psaty BM; Reiner AP; Schwartz SM; Cushman M
    J Thromb Haemost; 2007 Jun; 5(6):1128-35. PubMed ID: 17388967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poor Oral Health and Inflammatory, Hemostatic, and Cardiac Biomarkers in Older Age: Results From Two Studies in the UK and USA.
    Kotronia E; Wannamethee SG; Papacosta AO; Whincup PH; Lennon LT; Visser M; Kapila YL; Weyant RJ; Ramsay SE
    J Gerontol A Biol Sci Med Sci; 2021 Jan; 76(2):346-351. PubMed ID: 32306041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relation between Arterial Stiffness and Markers of Inflammation and Hemostasis - Data from the Population-based Gutenberg Health Study.
    Arnold N; Gori T; Schnabel RB; Schulz A; Prochaska JH; Zeller T; Binder H; Pfeiffer N; Beutel M; Espinola-Klein C; Lackner KJ; Blankenberg S; Münzel T; Wild PS
    Sci Rep; 2017 Jul; 7(1):6346. PubMed ID: 28740206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemostatic factors and risk of cardiovascular disease in women. An overview.
    Meilahn EN
    Arch Pathol Lab Med; 1992 Dec; 116(12):1313-7. PubMed ID: 1456877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CVD-related Fit-Fat Index on inflammatory-based CVD biomarkers.
    Loprinzi PD; Edwards MK
    Int J Cardiol; 2016 Nov; 223():284-285. PubMed ID: 27541674
    [No Abstract]   [Full Text] [Related]  

  • 7. Study of cardiovascular risk factors and hemostatic molecular markers in elderly persons.
    Deguchi K; Deguchi A; Wada H; Murashima S
    Semin Thromb Hemost; 2000; 26(1):23-7. PubMed ID: 10805277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relation of the prothrombotic state to increasing age (from the Framingham Offspring Study).
    Tofler GH; Massaro J; Levy D; Mittleman M; Sutherland P; Lipinska I; Muller JE; D'Agostino RB
    Am J Cardiol; 2005 Nov; 96(9):1280-3. PubMed ID: 16253598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of circulating inflammatory factors in prognosis and risk of cardiovascular disease.
    Haybar H; Shokuhian M; Bagheri M; Davari N; Saki N
    J Mol Cell Cardiol; 2019 Jul; 132():110-119. PubMed ID: 31102585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obesity, inflammatory markers and cardiovascular disease: distinguishing causality from confounding.
    Franks PW
    J Hum Hypertens; 2006 Nov; 20(11):837-40. PubMed ID: 16855628
    [No Abstract]   [Full Text] [Related]  

  • 11. Hemostasis, inflammation and cardiovascular disease.
    Páramo JA; Orbe J
    Clin Lab; 2002; 48(9-10):463-70. PubMed ID: 12389705
    [No Abstract]   [Full Text] [Related]  

  • 12. Biomarkers. Screening for C-reactive protein in CVD prediction.
    Peters SA; Visseren FL; Grobbee DE
    Nat Rev Cardiol; 2013 Jan; 10(1):12-4. PubMed ID: 23165068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of Blood-Borne Microparticles in Inflammation and Hemostasis.
    Suades R; Padró T; Badimon L
    Semin Thromb Hemost; 2015 Sep; 41(6):590-606. PubMed ID: 26276937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Guanidinoacetic Acid Loading on Biomarkers of Cardiometabolic Risk and Inflammation.
    Ostojic SM; Trivic T; Drid P; Stajer V; Vranes M
    Ann Nutr Metab; 2018; 72(1):18-20. PubMed ID: 29232678
    [No Abstract]   [Full Text] [Related]  

  • 15. Longitudinal changes in hemostatic factors in CAPD patients.
    Lee MS; Yang WS; Lee SK; Park JS; Chi HS; Kim SB
    Perit Dial Int; 2002; 22(4):518-20. PubMed ID: 12322826
    [No Abstract]   [Full Text] [Related]  

  • 16. Hemostatic and inflammatory markers as risk factors for coronary disease in the elderly.
    Tracy RP
    Am J Geriatr Cardiol; 2002; 11(2):93-100, 107. PubMed ID: 11872967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Etiopathogenesis of cardiovascular disease: hemostasis, thrombosis, and vascular medicine.
    Lowe GD
    Ann Periodontol; 1998 Jul; 3(1):121-6. PubMed ID: 9722696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between circulating microparticles and hypertension and other cardiac disease biomarkers in the elderly.
    Usta Atmaca H; Akbas F; Aral H
    BMC Cardiovasc Disord; 2019 Jul; 19(1):164. PubMed ID: 31288734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular disease in patients with inflammatory bowel disease: An issue in no guidelines land.
    Zuin M; Rigatelli G; Del Favero G; Andreotti AN; Picariello C; Zuliani G; Carraro M; Galasso MP; Roncon L
    Int J Cardiol; 2016 Nov; 222():984-985. PubMed ID: 27526375
    [No Abstract]   [Full Text] [Related]  

  • 20. Hemostatic/fibrinolytic markers and cardiovascular risk factors in schoolchildren.
    Kawada T
    Blood Coagul Fibrinolysis; 2016 Mar; 27(2):233. PubMed ID: 26825494
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.